Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 19, 2025
A multivalent nanoparticle vaccine elicits potent neutralizing antibody response against monkeypox virusRun-Yu Yuan, Meng-Jun Li, Xiao-Bing Lin, et al.Bing Du Xue Bao = Chinese Journal of Virology|June 25, 2010
[Cloning and analysis of full-length genes of a H9N2 subtype avian influenza virus isolated from Guangdong]Yan Qi, Run-yu Yuan, He-nan Zhang, et al.Journal of Virology|June 14, 2022
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle VaccinesCong Sun, Run-Yu Yuan, Chu Xie, et al.Virus Evolution|January 4, 2021
Exploring utility of genomic epidemiology to trace origins of highly pathogenic influenza A/H7N9 in GuangdongRu Bai, Reina S Sikkema, Bas B Oude Munnink, et al.Nature Communications|May 13, 2022
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variantsYin-Feng Kang, Cong Sun, Jing Sun, et al.Cell Reports|October 2, 2025
A single-dose nanoparticle vaccine protects against mpox in preclinical modelsRun-Yu Yuan, Meng-Jun Li, Xiao-Bing Lin, et al.Biomedical and Environmental Sciences : BES|January 4, 2022
Kinetic Characteristics of Neutralizing Antibody Responses Vary among Patients with COVID-19Ling Hua Li, Hong Wei Tu, Dan Liang, et al.ACS Nano|January 19, 2021
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine CandidatesYin-Feng Kang, Cong Sun, Zhen Zhuang, et al.Cell Discovery|February 16, 2022
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2Yu Liang, Jing Zhang, Run Yu Yuan, et al.Pageof 1